loadpatents
name:-0.030169010162354
name:-0.012965202331543
name:-0.01595401763916
Jin; Hee Kyung Patent Filings

Jin; Hee Kyung

Patent Applications and Registrations

Patent applications and USPTO patent grants for Jin; Hee Kyung.The latest application filed is for "method for treating a degenerative neurological disorders comprising administering asm inhibitor".

Company Profile
13.12.22
  • Jin; Hee Kyung - Daegu KR
  • - Daegu KR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Phenylsulfonyl oxazole derivative and use thereof
Grant 11,345,671 - Bae , et al. May 31, 2
2022-05-31
Method For Treating A Degenerative Neurological Disorders Comprising Administering Asm Inhibitor
App 20220135703 - BAE; Jae Sung ;   et al.
2022-05-05
Neuropeptide Y fragment capable of releasing hematopoietic stem cells into blood and treating osteoporosis
Grant 11,279,744 - Bae , et al. March 22, 2
2022-03-22
Method for treating a neurological disorder comprising administering ASM inhibitors
Grant 11,242,529 - Bae , et al. February 8, 2
2022-02-08
Composition For Diagnosing Diseases Associated With Cox2 Overexpression And Screening Method Therefor
App 20210270834 - BAE; Jae-Sung ;   et al.
2021-09-02
2-amino-2-(1,2,3-triazole-4-yl)propane-1,3-diol Derivative Of Novel Compound For Directly Inhibiting Asm Activity, And Use Thereof
App 20210188784 - BAE; Jae-Sung ;   et al.
2021-06-24
Pharmaceutical composition containing stem cell in which vascular endothelial growth factor is overexpressed as effective ingredient for preventing or treating neurodegenerative disease
Grant 11,007,228 - Bae , et al. May 18, 2
2021-05-18
Pharmaceutical Composition For Preventing Or Treating Degenerative Brain Disorders Including Hdl-apom-s1p As Active Ingredient
App 20210085697 - Bae; Jae Sung ;   et al.
2021-03-25
Novel Phenylsulfonyl Oxazole Derivative And Use Thereof
App 20210070718 - BAE; Jae Sung ;   et al.
2021-03-11
Composition For Diagnosis Of Degenerative Neurological Diseases
App 20210003595 - BAE; Jae-Sung ;   et al.
2021-01-07
Pharmaceutical Composition For Preventing Or Treating Neurodegenerative Diseases Comprising Cox2 Acetylating Agent As Active Ingredient
App 20210003594 - BAE; Jae-Sung ;   et al.
2021-01-07
Pharmaceutical Composition For Preventing Or Treating Neurodegenerative Disease, Containing, As Active Ingredients, Cyclodextrin And Stem Cells In Which Vegf Is Overexpressed
App 20200353009 - BAE; Jae Sung ;   et al.
2020-11-12
Method For Treating A Degenerative Neurological Disorders Comprising Administering Asm Inhibitor
App 20200255839A1 -
2020-08-13
Method for treating a degenerative neurological disorders comprising administering ASM inhibitor
Grant 10,682,373 - Bae , et al.
2020-06-16
Novel Peptide Exhibiting Effect Of Releasing Hematopoietic Stem Cells Into Blood And Osteoporosis Therapeutic Effect And Use The
App 20200172592 - Bae; Jae Sung ;   et al.
2020-06-04
Amyotrophic Lateral Sclerosis Diagnostic Composition Using Acid Sphingomyelinase, And Method For Detecting Diagnostic Markers
App 20200080129 - BAE; Jae-Sung ;   et al.
2020-03-12
Composition containing neuropeptide Y for inhibiting side effects of anticancer agents
Grant 10,543,254 - Bae , et al. Ja
2020-01-28
Peptides for treating bone diseases and use thereof
Grant 10,323,064 - Bae , et al.
2019-06-18
Pharmaceutical Composition Containing Stem Cell In Which Vascular Endothelial Growth Factor Is Overexpressed As Effective Ingredient For Preventing Or Treating Neurodegenerative Disease
App 20190030082 - Bae; Jae Sung ;   et al.
2019-01-31
Method using an Y1 receptor activator for treating an anticancer agent-induced nephrotoxic injury
Grant 10,143,727 - Bae , et al. De
2018-12-04
Composition comprising ASM inhibitor as active ingredient for preventing or treating degenerative neurological disorders
Grant 10,098,855 - Bae , et al. October 16, 2
2018-10-16
Method For Treating A Degenerative Neurological Disorders Comprising Administering Asm Inhibitor
App 20180264027 - Bae; Jae Sung ;   et al.
2018-09-20
Novel Peptides For Preventing Or Treating Bone Diseases And Use Thereof
App 20170267723 - BAE; JAE SUNG ;   et al.
2017-09-21
Y1 receptor activator for treating an anticancer agent-induced nephrotoxic injury
App 20170224781 - Bae; Jae Sung ;   et al.
2017-08-10
Method for treating a neurodegenerative disease or depression comprising administering derivatives of 2-amino-2-(1-dodecyl-1H-1,2,3-triazol-4-yl)propane-1,3-diol
Grant 9,724,334 - Bae , et al. August 8, 2
2017-08-08
Pharmaceutical composition for preventing or treating osteoporosis which comprises neuropeptide Y as active ingredient
Grant 9,724,394 - Bae , et al. August 8, 2
2017-08-08
Composition Containing Neuropeptide Y For Inhibiting Side Effects Of Anticancer Agents
App 20170189491 - Bae; Jae Sung ;   et al.
2017-07-06
Novel Peptides For Preventing Or Treating Bone Diseases And Use Thereof
App 20170183381 - Bae; Jae Sung ;   et al.
2017-06-29
Peptides for preventing or treating bone diseases and use thereof
Grant 9,650,420 - Bae , et al. May 16, 2
2017-05-16
Novel Peptides for Preventing or Treating Bone Diseases and Use Thereof
App 20170081366 - Bae; Jae Sung ;   et al.
2017-03-23
Peptides For Preventing Or Treating Bone Diseases And Use Thereof
App 20170081367 - Bae; Jae Sung ;   et al.
2017-03-23
Pharmaceutical Composition for Preventing or Treating Osteoporosis Which Comprises Neuropeptide Y as Active Ingredient
App 20160243198 - Bae; Jae Sung ;   et al.
2016-08-25
Composition Comprising Asm Inhibitor As Active Ingredient For Preventing Or Treating Degenerative Neurological Disorders
App 20160101070 - Bae; Jae Sung ;   et al.
2016-04-14
Composition Comprising AMD3100 For Preventing or Treating Bone Diseases
App 20160081980 - Bae; Jae Sung ;   et al.
2016-03-24
Composition For Preventing Or Treating Neurodegenerative Diseases Containing Ccl5
App 20130225498 - BAE; Jae-Sung ;   et al.
2013-08-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed